Physician profile
Casey Isom
NPI 1215964275
$7,038.84
in general payments reported to CMS, 2019-2025
13 companies · $559 in 2025
The $559 reported for 2025 was more than what 81% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,886 · 2021: $60.22 · 2022: $192 · 2023: $143 · 2024: $3,198 · 2025: $559.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,421 · Food and Beverage: $1,479.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,421.00 |
| Food and Beverage | $1,479.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,841.43 | 2024-2025 | |
| Allergan, INC. | $1,410.68 | 2019 | |
| Axogen | $1,395.99 | 2019 | |
| Tela Bio, INC. | $695.32 | 2024 | Ovitex 2s |
| Sientra, INC. | $205.61 | 2021-2022 | |
| Integra Lifesciences Corporation | $187.84 | 2023-2025 | Integra, Integra Dermal Regeneration Template, Omnigraft |
| Davol INC. | $92.03 | 2022-2023 | Phasix Mesh |
| Pacira Pharmaceuticals Incorporated | $68.92 | 2019-2025 | Exparel |
| Covidien Lp | $46.41 | 2019 | |
| Merck Sharp & Dohme LLC | $39.56 | 2022-2023 | Bridion |
| Endo Pharmaceuticals INC. | $27.57 | 2023 | Xiaflex |
| Acera Surgical, INC. | $15.62 | 2024 | Restrata Wound Matrix |
| Kci USA, INC. | $11.86 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Casey Isom listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.